Dr. Harkiratjit Singh Bhulla et al. 2025. LOW-DOSE NIVOLUMAB IN ADVANCED SOLID TUMOURS: ACTIVITY, TOXICITY AND THE MISSING COMPARISON WITH STANDARD DOSE. Journal of Population Therapeutics and Clinical Pharmacology. 32, 11 (Dec. 2025), 2230–2247. DOI:https://doi.org/10.67145/fchabf12.